« Back to Record
Citation APA

Molina, J.-M., Lamarca, A., Andrade-Villanueva, J., Clotet, B., Clumeck, N., Liu, Y.-P., Zhong, L., Margot, N., Cheng, A. K., & Chuck, S. L. (2012). Efficacy and safety of once daily elvitegravir versus twice daily raltegravir in treatment-experienced patients with HIV-1 receiving a ritonavir-boosted protease inhibitor: Randomised, double-blind, phase 3, non-inferiority study. Lancet. Infectious diseases, 12(1), 27-35. doi:10.1016/S1473-3099(11)70249-3


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/168039

Molina, J.-M., Lamarca, A., Andrade-Villanueva, J., Clotet, B., Clumeck, N., Liu, Y.-P., Zhong, L., Margot, N., Cheng, A. K., & Chuck, S. L. (2012). Efficacy and safety of once daily elvitegravir versus twice daily raltegravir in treatment-experienced patients with HIV-1 receiving a ritonavir-boosted protease inhibitor: Randomised, double-blind, phase 3, non-inferiority study. Lancet. Infectious diseases, 12(1), 27-35. doi:10.1016/S1473-3099(11)70249-3